IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
BIT:IVG - Euronext Milan - NL0015000LU4 - Common Stock - Currency: EUR
Overall IVG gets a fundamental rating of 5 out of 10. We evaluated IVG against 103 industry peers in the Machinery industry. IVG has an average financial health and profitability rating. IVG scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
IVG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
IVG has a Return On Assets (1.80%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 12.93%, IVG is in the better half of the industry, outperforming 75.73% of the companies in the same industry.
The Return On Invested Capital of IVG (5.25%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.41%.
The last Return On Invested Capital (5.25%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.8% | ||
| ROE | 12.93% | ||
| ROIC | 5.25% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG has a Profit Margin (2.28%) which is in line with its industry peers.
IVG's Profit Margin has improved in the last couple of years.
IVG has a Operating Margin of 6.14%. This is comparable to the rest of the industry: IVG outperforms 53.40% of its industry peers.
In the last couple of years the Operating Margin of IVG has grown nicely.
IVG has a worse Gross Margin (17.35%) than 86.41% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.14% | ||
| PM (TTM) | 2.28% | ||
| GM | 17.35% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
IVG has more shares outstanding than it did 5 years ago.
IVG has a better debt/assets ratio than last year.
2.2 Solvency
IVG has an Altman-Z score of 1.76. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
IVG's Altman-Z score of 1.76 is in line compared to the rest of the industry. IVG outperforms 43.69% of its industry peers.
The Debt to FCF ratio of IVG is 45.37, which is on the high side as it means it would take IVG, 45.37 years of fcf income to pay off all of its debts.
IVG's Debt to FCF ratio of 45.37 is on the low side compared to the rest of the industry. IVG is outperformed by 67.96% of its industry peers.
IVG has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.47, IVG is doing worse than 84.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 45.37 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.75
WACC6.97%
2.3 Liquidity
A Current Ratio of 2.16 indicates that IVG has no problem at all paying its short term obligations.
IVG's Current ratio of 2.16 is fine compared to the rest of the industry. IVG outperforms 78.64% of its industry peers.
A Quick Ratio of 1.67 indicates that IVG should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.67, IVG belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.16 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
IVG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.10%, which is quite impressive.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
IVG shows a decrease in Revenue. In the last year, the revenue decreased by -5.70%.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)98.1%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%206.25%
Revenue 1Y (TTM)-5.7%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-6.56%
3.2 Future
Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.94% on average per year.
IVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.51% yearly.
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y11.94%
Revenue Next Year0.61%
Revenue Next 2Y2.74%
Revenue Next 3Y4.05%
Revenue Next 5Y2.51%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.92 indicates a rather cheap valuation of IVG.
IVG's Price/Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 91.26% of the companies in the same industry.
IVG is valuated cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.19, the valuation of IVG can be described as very cheap.
Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 92.23% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.81, IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.92 | ||
| Fwd PE | 7.19 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVG is valued cheaply inside the industry as 85.44% of the companies are valued more expensively.
IVG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.1 | ||
| EV/EBITDA | 4.17 |
4.3 Compensation for Growth
IVG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y7.38%
EPS Next 3Y10.65%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.36%, IVG has a reasonable but not impressive dividend return.
IVG's Dividend Yield is a higher than the industry average which is at 2.96.
Compared to an average S&P500 Dividend Yield of 2.45, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
26.07% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP26.07%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
BIT:IVG (5/5/2025, 5:07:20 PM)
14.4
+0.04 (+0.31%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.91B
Analysts77.33
Price Target16.6 (15.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP26.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.4%
Min EPS beat(2)7.26%
Max EPS beat(2)63.53%
EPS beat(4)4
Avg EPS beat(4)60.23%
Min EPS beat(4)7.26%
Max EPS beat(4)122.78%
EPS beat(8)5
Avg EPS beat(8)13.96%
EPS beat(12)7
Avg EPS beat(12)6.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.11%
Min Revenue beat(2)0.94%
Max Revenue beat(2)9.28%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-6.08%
Max Revenue beat(4)9.28%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)8
Avg Revenue beat(12)3.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.75%
PT rev (3m)25.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.45%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)2.6%
Revenue NQ rev (1m)-3.56%
Revenue NQ rev (3m)6.21%
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.92 | ||
| Fwd PE | 7.19 | ||
| P/S | 0.26 | ||
| P/FCF | 28.1 | ||
| P/OCF | 3.59 | ||
| P/B | 1.45 | ||
| P/tB | 5.92 | ||
| EV/EBITDA | 4.17 |
EPS(TTM)2.08
EY14.44%
EPS(NY)2
Fwd EY13.91%
FCF(TTM)0.51
FCFY3.56%
OCF(TTM)4.02
OCFY27.88%
SpS56.37
BVpS9.95
TBVpS2.43
PEG (NY)N/A
PEG (5Y)0.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.8% | ||
| ROE | 12.93% | ||
| ROCE | 6.94% | ||
| ROIC | 5.25% | ||
| ROICexc | 7.02% | ||
| ROICexgc | 8.78% | ||
| OM | 6.14% | ||
| PM (TTM) | 2.28% | ||
| GM | 17.35% | ||
| FCFM | 0.91% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score7
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 45.37 | ||
| Debt/EBITDA | 2.45 | ||
| Cap/Depr | 140.12% | ||
| Cap/Sales | 6.21% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 39.83% | ||
| Current Ratio | 2.16 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 1.76 |
F-Score7
WACC6.97%
ROIC/WACC0.75
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.1%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%206.25%
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y11.94%
Revenue 1Y (TTM)-5.7%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-6.56%
Revenue Next Year0.61%
Revenue Next 2Y2.74%
Revenue Next 3Y4.05%
Revenue Next 5Y2.51%
EBIT growth 1Y4.22%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year83.42%
EBIT Next 3Y31.17%
EBIT Next 5YN/A
FCF growth 1Y-62.02%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-18.49%
OCF growth 3Y26.42%
OCF growth 5Y8.96%